SCHEMBL5790015

SCHEMBL5790015

CC(C)=CCc1cc(/C=C/C(=O)O)cc2c1OC(C(C)CO)C2

nearest known ligand 0.51

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 19/20 0.51
▸ AKR1B10 O60218 2/20 0.51
▸ AKR1B1 P15121 2/20 0.51
▸ MMP2 P08253 1/20 0.51
▸ PAK1 Q13153 1/20 0.51
▸ AKR1C2 P52895 17/20 0.43
▸ AKR1C4 P17516 1/20 0.39
▸ PTGES O14684 1/20 0.36
▸ ALOX5 P09917 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ STAT3 P40763 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28367910 1.00 AKR1C3 (0.51) AKR1C3AKR1B10AKR1B1MMP2PAK1
SCHEMBL3375377 0.80 AKR1C3 (0.54) AKR1C3AKR1B10AKR1B1MMP2PAK1
SCHEMBL3375374 0.80 AKR1C3 (0.54) AKR1C3AKR1B10AKR1B1MMP2PAK1
SCHEMBL15397968 0.76 AKR1C3 (0.54) AKR1C3AKR1B10AKR1B1MMP2PAK1
SCHEMBL15397966 0.76 AKR1C3 (0.54) AKR1C3AKR1B10AKR1B1MMP2PAK1
Artepillin SCHEMBL7128580 0.69 AKR1C3 (1.00) AKR1C3AKR1B10AKR1B1MMP2PAK1
Artepillin SCHEMBL2138507 0.69 AKR1C3 (1.00) AKR1C3AKR1B10AKR1B1MMP2PAK1
Artepillin SCHEMBL1229229 0.69 AKR1C3 (1.00) AKR1C3AKR1B10AKR1B1MMP2PAK1
SCHEMBL3684666 0.68 AKR1C3 (0.80) AKR1C3AKR1B10AKR1B1MMP2PAK1
SCHEMBL3684668 0.68 AKR1C3 (0.80) AKR1C3AKR1B10AKR1B1MMP2PAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006004358-A1 DICOUMAROL-REMOVED EXTRACT OF ARTEMISIA, PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF DONG-A PHARM. CO., LTD. (KR) 2006-01-12 — — WO disclosed
Send feedback